HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) (HAL)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2009 by University of Texas Southwestern Medical Center.
Recruitment status was Recruiting

Sponsor:

Collaborator:

Takeda Pharmaceuticals North America, Inc.

Information provided by:

University of Texas Southwestern Medical Center

ClinicalTrials.gov Identifier:

NCT01023620

First received: November 30, 2009

Last updated: December 1, 2009

Last verified: December 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2010
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)